Thursday, November 02, 2017 10:15 PM ET
Significant Insider Sales in Shares of NovoCure (NVCR) Extends the Selling Trend of Last Quarter
SEC filings today revealed notable insider sales of NovoCure shares as three insiders — Eilon D Kirson, Officer, Michael J Ambrogi, Officer, and Asaf Danziger, Director and Officer — sold 62,462 shares in the company having a market value of approximately $1,374,644. In the past 90 days prior to this transaction there was one insider buy/sell transaction which resulted in the sale of 38,172 shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 100,634 shares and have averaged 25,159 shares per transaction over this time period.
The number of insider buy/sell trades at NovoCure is above that of the 269 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 325 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares traded per transaction by NovoCure insiders is lower than its peers. Within the peer group there were 25,993,161 shares purchased and 12,321,469 shares sold with company insiders acquiring 66,691 shares on average over this time period.
The data obtained in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Today’s Insider Activity
* Eilon D Kirson, Officer, sold 22,269 shares
* Michael J Ambrogi, Officer, sold 24,327 shares
* Asaf Danziger, Director and Officer, sold 15,866 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.